Winthrop Advisory Group
ABBV icon

Winthrop Advisory Group’s AbbVie ABBV Stock Holding History

Winthrop Advisory Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.33M Buy
5,088
+144
+3% +$36.9K 0.08% 73
2026
Q2 		$1.24M Buy
4,944
+406
+9% +$87.3K 0.08% 79
2026
Q1 		$987K Sell
4,538
-183
-4% -$40.6K 0.08% 75
2025
Q4 		$1.07M Buy
4,721
+255
+6% +$58.1K 0.09% 69
2025
Q3 		$1.03M Sell
4,466
-89
-2% -$18.1K 0.09% 68
2025
Q2 		$845K Buy
4,555
+1,450
+47% +$269K 0.08% 74
2025
Q1 		$651K Sell
3,105
-1,389
-31% -$270K 0.08% 74
2024
Q4 		$799K Buy
4,494
+1,149
+34% +$211K 0.1% 69
2024
Q3 		$661K Sell
3,345
-67
-2% -$12.5K 0.08% 73
2024
Q2 		$585K Sell
3,412
-170
-5% -$28.2K 0.08% 73
2024
Q1 		$652K Buy
3,582
+78
+2% +$13.4K 0.09% 67
2023
Q4 		$543K Sell
3,504
-58
-2% -$8.46K 0.08% 72
2023
Q3 		$531K Buy
3,562
+124
+4% +$18.2K 0.09% 67
2023
Q2 		$463K Buy
3,438
+26
+0.8% +$3.81K 0.07% 78
2023
Q1 		$544K Buy
3,412
+9
+0.3% +$1.38K 0.1% 68
2022
Q4 		$550K Sell
3,403
-1,041
-23% -$160K 0.1% 67
2022
Q3 		$596K Buy
4,444
+1
+0% +$143 0.13% 56
2022
Q2 		$680K Buy
4,443
+1
+0% +$153 0.16% 50
2022
Q1 		$720K Buy
4,442
+502
+13% +$72.9K 0.15% 53
2021
Q4 		$533K Buy
3,940
+11
+0.3% +$1.3K 0.11% 65
2021
Q3 		$424K Buy
3,929
+1,804
+85% +$206K 0.09% 65
2021
Q2 		$239K Sell
2,125
-18
-0.8% -$2.03K 0.05% 113
2021
Q1 		$232K Buy
2,143
+16
+0.8% +$1.71K 0.06% 116
2020
Q4 		$228K Buy
+2,127
New +$204K 0.06% 112

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
ABN AMRO Investment Solutions
ABN AMRO Investment Solutions Paris Cedex 008 $13.2B AUM 30.55% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Winthrop Advisory Group's ABBV Position: Q3 2026 in Review

Winthrop Advisory Group increased its AbbVie (ABBV) stake by 2.9% in Q3 2026, buying an estimated $36.9K and bringing the position to 5,088 shares worth $1.33M. The position accounts for 0.08% of the portfolio, ranked #73.

Winthrop Advisory Group first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. 1,436 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Winthrop Advisory Group held 5,088 shares of AbbVie worth $1.33M as of Q3 2026.
  • Winthrop Advisory Group bought 144 AbbVie shares in Q3 2026, an estimated $36.9K.
  • AbbVie made up 0.08% of Winthrop Advisory Group's portfolio in Q3 2026, its #73 holding.
  • Winthrop Advisory Group first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
  • 1,436 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Winthrop Advisory Group's 13F filing for Q3 2026, filed 22 Oct 2026.